Bioventus Inc.BVSNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank75
5Y CAGR+3.5%
Year-over-Year Change
Year-over-year operating cash flow growth rate
5Y CAGR
+3.5%/yr
Long-term compound
Percentile
P75
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 90.68% |
| 2024 | 152.83% |
| 2023 | 213.35% |
| 2022 | -158.88% |
| 2021 | -67.98% |
| 2020 | 76.35% |
| 2019 | -9.90% |
| 2018 | 0.00% |
| 2017 | 0.00% |
| 2016 | 0.00% |